国际肿瘤学杂志 ›› 2011, Vol. 38 ›› Issue (11): 829-832.

• 综述 • 上一篇    下一篇

伴侣分子抗原肽瘤苗的抗肿瘤机制

姜贻乾, 黄常新, 李朝阳, 等   

  1. 310015 杭州,浙江中医药大学(姜贻乾、李朝阳、段广亮);杭州师范大学附属医院肿瘤科(黄常新)
  • 出版日期:2011-11-08 发布日期:2011-11-03
  • 通讯作者: 黄常新,Email:hcx588@hotmail.com E-mail:hcx588@hotmail.com

Anti-tumor mechanisms of companion member antigen peptide tumor vaccine

JIANG  Yi-Qian, HUANG  Chang-Xin, LI  Chao-Yang, et al    

  1. Zhejiang University of Traditional Chinese Medicine, Hangzhou 310015, China
  • Online:2011-11-08 Published:2011-11-03

摘要: 肿瘤疫苗已成为肿瘤免疫治疗研究的热点,伴侣分子抗原肽瘤苗因其化学性质稳定、易于制备、无潜在致癌性等优点,更是受到广泛关注。伴侣分子抗原肽瘤苗可通过伴侣分子的抗原提呈、增强机体的非特异行抗肿瘤机制以及激活特异性肿瘤免疫机制等多种途径发挥作用,其抗肿瘤机制的多样性等优点在肿瘤的临床免疫治疗中将有着积极的作用。

Abstract: With the continuous development of tumor immunology, cancer vaccines have become a hot spot of tumor immunotherapy. Companion member antigen peptide tumor vaccine attracts widely attention because of its chemical stability, easy preparation and no carcinogenic potential advantage. Companion member antigen peptide tumor vaccine may work through many kinds of ways including the function of antigen presenting, enhancing the body's non-specific line of anti-tumor mechanisms and activating the tumor-specific immune mechanism. Its different anti-tumor mechanisms merits and so on will have positive function in the tumor clinical immunity treatment.